208 related articles for article (PubMed ID: 26267155)
1. Comparison of biomarkers for systemic juvenile idiopathic arthritis.
Shenoi S; Ou JN; Ni C; Macaubas C; Gersuk VH; Wallace CA; Mellins ED; Stevens AM
Pediatr Res; 2015 Nov; 78(5):554-9. PubMed ID: 26267155
[TBL] [Abstract][Full Text] [Related]
2. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.
Aljaberi N; Tronconi E; Schulert G; Grom AA; Lovell DJ; Huggins JL; Henrickson M; Brunner HI
Pediatr Rheumatol Online J; 2020 Jan; 18(1):7. PubMed ID: 31948488
[TBL] [Abstract][Full Text] [Related]
3. Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.
Ling XB; Park JL; Carroll T; Nguyen KD; Lau K; Macaubas C; Chen E; Lee T; Sandborg C; Milojevic D; Kanegaye JT; Gao S; Burns J; Schilling J; Mellins ED
Proteomics; 2010 Dec; 10(24):4415-30. PubMed ID: 21136595
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
Front Immunol; 2018; 9():2995. PubMed ID: 30619348
[No Abstract] [Full Text] [Related]
5. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Yasin S; Fall N; Brown RA; Henderlight M; Canna SW; Girard-Guyonvarc'h C; Gabay C; Grom AA; Schulert GS
Rheumatology (Oxford); 2020 Feb; 59(2):361-366. PubMed ID: 31326996
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis.
Hügle B; Schippers A; Fischer N; Ohl K; Denecke B; Ticconi F; Vastert B; Costa IG; Haas JP; Tenbrock K
Arthritis Res Ther; 2018 May; 20(1):98. PubMed ID: 29848367
[TBL] [Abstract][Full Text] [Related]
7. Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
Xia Y; Cui P; Li Q; Liang F; Li C; Yang J
Braz J Med Biol Res; 2017 Feb; 50(2):e5958. PubMed ID: 28225869
[TBL] [Abstract][Full Text] [Related]
8. S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.
Yamasaki Y; Takei S; Imanaka H; Kubota T; Nonaka Y; Takezaki T; Kawano Y
Clin Rheumatol; 2019 Mar; 38(3):835-840. PubMed ID: 30406853
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Gorelik M; Fall N; Altaye M; Barnes MG; Thompson SD; Grom AA; Hirsch R
J Rheumatol; 2013 Jul; 40(7):1191-9. PubMed ID: 23678162
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.
Nirmala N; Grom A; Gram H
Curr Opin Rheumatol; 2014 Sep; 26(5):543-52. PubMed ID: 25050926
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis.
Sun J; Feng M; Wu F; Ma X; Lu J; Kang M; Liu Z
J Rheumatol; 2016 Aug; 43(8):1607-14. PubMed ID: 27252421
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis.
Gohar F; McArdle A; Jones M; Callan N; Hernandez B; Kessel C; Miranda-Garcia M; Lavric M; Holzinger D; Pretzer C; Lainka E; Vastert SJ; de Roock S; FitzGerald O; Pennington SR; Foell D
Ann Rheum Dis; 2019 Aug; 78(8):1107-1113. PubMed ID: 31005900
[TBL] [Abstract][Full Text] [Related]
13. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.
Wittkowski H; Frosch M; Wulffraat N; Goldbach-Mansky R; Kallinich T; Kuemmerle-Deschner J; Frühwald MC; Dassmann S; Pham TH; Roth J; Foell D
Arthritis Rheum; 2008 Dec; 58(12):3924-31. PubMed ID: 19035478
[TBL] [Abstract][Full Text] [Related]
14. Establishment and analysis of a novel diagnostic model for systemic juvenile idiopathic arthritis based on machine learning.
Ding P; Du Y; Jiang X; Chen H; Huang L
Pediatr Rheumatol Online J; 2024 Jan; 22(1):18. PubMed ID: 38243323
[TBL] [Abstract][Full Text] [Related]
15. Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study.
Qu H; Sundberg E; Aulin C; Neog M; Palmblad K; Horne AC; Granath F; Ek A; Melén E; Olsson M; Harris HE
Pediatr Rheumatol Online J; 2021 Dec; 19(1):173. PubMed ID: 34963488
[TBL] [Abstract][Full Text] [Related]
16. Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.
Ling XB; Macaubas C; Alexander HC; Wen Q; Chen E; Peng S; Sun Y; Deshpande C; Pan KH; Lin R; Lih CJ; Chang SY; Lee T; Sandborg C; Begovich AB; Cohen SN; Mellins ED
BMC Med; 2012 Oct; 10():125. PubMed ID: 23092393
[TBL] [Abstract][Full Text] [Related]
17. Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis.
Cai L; Zhang C; Wu J; Zhou W; Chen T
Clin Immunol; 2021 Aug; 229():108800. PubMed ID: 34289424
[TBL] [Abstract][Full Text] [Related]
18. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
20. The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.
Holzinger D; Frosch M; Kastrup A; Prince FH; Otten MH; Van Suijlekom-Smit LW; ten Cate R; Hoppenreijs EP; Hansmann S; Moncrieffe H; Ursu S; Wedderburn LR; Roth J; Foell D; Wittkowski H
Ann Rheum Dis; 2012 Jun; 71(6):974-80. PubMed ID: 22267331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
